"LITE"程序与短期抗生素治疗相结合,可以有效治疗慢性PJI吗? - - 一个潜在的随机对照试验
Yang Chen1,2,3, Haiqi Ding1,2,3, Qijin Wang1,2,3
1Department of Orthopaedic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Orthopaedic surgery
|October 20, 2024
概括
在长时间间隔两阶段交换 (LITE) 后,对周围假肢关节感染 (PJI) 进行短暂的2周抗生素疗程,与12周疗程一样有效. 这一发现简化了慢性PJI患者的治疗.
科学领域:
- 整形外科手术 整形外科手术
- 传染性疾病 传染性疾病
- 临床试验 临床试验
背景情况:
- 慢性周假肢关节感染 (PJI) 治疗通常涉及两个阶段的交换.
- 抗生素治疗的最佳持续时间在手术后进行辩论.
- 长间隔两阶段交换 (LITE) 是慢性PJI的一种常见方法.
研究的目的:
- 评估短暂的术后抗生素疗程 (2周) 是否与慢性PJI患者接受LITE的长期 (12周) 感染控制疗程不劣.
- 为了确定减少抗生素持续时间在LITE后慢性PJI管理中的有效性.
主要方法:
- 对60名慢性PJI患者进行LITE的前性随机研究.
- 患者接受了2周或12周的术后抗生素治疗.
- 使用Kaplan-Meier分析在至少24个月的随访期间比较感染控制率.
主要成果:
- 短期 (96.7%) 和长期 (96.7%) 组之间的感染控制率没有显著差异.
- 这两种治疗持续时间都在预防重新感染或重新手术方面表现出相似的有效性.
- 该研究达到其非劣势终点.
结论:
- 术后两周的抗生素治疗方案足以维持LITE治疗的慢性PJI患者的感染控制.
- 这种较短的持续时间简化了治疗,并可能减少与抗生素相关的并发症.
- 结果支持在特定的PJI管理协议中降低抗生素治疗时间的升级.
相关概念视频
Acute Pyelonephritis II: Diagnostic Studies and Management
1
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
1
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pneumonia IV: Management
302
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
302
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328


